Lexaria Bioscience Corp (LEXX)

NASDAQ
Currency in USD
1.900
-0.075(-4.05%)
Closed
After Hours
1.980+0.080(+4.211%)
LEXX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected today
Fair Value
Day's Range
1.8902.041
52 wk Range
1.3606.850
Key Statistics
Edit
Prev. Close
1.9
Open
1.97
Day's Range
1.89-2.041
52 wk Range
1.36-6.85
Volume
48.31K
Average Vol. (3m)
196.53K
1-Year Change
29.25%
Book Value / Share
0.56
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LEXX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
10.000
Upside
+426.32%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Lexaria Bioscience Corp Company Profile

Lexaria Bioscience Corp. operates as a biotechnology company. It offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. The company’s DehydraTECH is used with a range of active molecules, including glucagon-like peptide-1 drugs (GLP-1) and glucose -dependent insulinotropic polypeptide drugs (GIP), vitamins, pain medications, hormones, phosphodiesterase type 5 (PDE5) inhibitors, antivirals, nicotine and its analogs, and cannabinoids. Its DehydraTECH technology is applied to various therapeutic indications, such as diabetes, weight loss, hypertension, and heart disease; is implemented in a multitude of ingestible or topically administered product formats comprising oral suspensions, tablets, capsules, foods, beverages, creams, lotions, and skin patches; and is suitable for a variety of product formats, including pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.

Employees
7

Compare LEXX to Peers and Sector

Metrics to compare
LEXX
Peers
Sector
Relationship
P/E Ratio
−4.6x−1.9x−0.6x
PEG Ratio
−0.12−0.020.00
Price / Book
3.4x0.1x2.6x
Price / LTM Sales
67.1x1.4x3.1x
Upside (Analyst Target)
-37.6%54.6%
Fair Value Upside
Unlock13.3%7.7%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 10.000
(+426.32% Upside)

Earnings

Latest Release
Oct 30, 2024
EPS / Forecast
-0.14 / -0.12
Revenue / Forecast
84.00K / 200.00K
EPS Revisions
Last 90 days

People Also Watch

1.030
LOOP
+3.00%
4.5800
IDAI
+3.85%
17.61
PLSE
-0.17%
2.530
CPIX
-8.66%

FAQ

What Is the Lexaria Bioscience (LEXX) Stock Price Today?

The Lexaria Bioscience stock price today is 1.90

What Stock Exchange Does Lexaria Bioscience Trade On?

Lexaria Bioscience is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Lexaria Bioscience?

The stock symbol for Lexaria Bioscience is "LEXX."

What Is the Lexaria Bioscience Market Cap?

As of today, Lexaria Bioscience market cap is 33.35M.

What is Lexaria Bioscience Earnings Per Share?

The Lexaria Bioscience EPS is -0.512.

What Is the Next Lexaria Bioscience Earnings Date?

Lexaria Bioscience will release its next earnings report on Jan 21, 2025.

From a Technical Analysis Perspective, Is LEXX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.